Croma-Pharma
Clemens Cantelmo is a seasoned professional in regulatory affairs, currently serving as the Regulatory Affairs Manager at CROMA-PHARMA since May 2020, after holding the position of Regulatory Affairs Assistant. Prior experience includes roles at Pint Pharma from February 2015 to May 2020, where Clemens worked as an Assistant to the Legal Department and as an Executive Assistant to the CEO. Clemens holds a Bachelor of Science in Agricultural Science from the University of Natural Resources and Life Sciences, Vienna (BOKU), completed in June 2019, and a Bachelor of Arts in Transcultural Communication from the University of Vienna, completed in June 2014.
This person is not in any offices
Croma-Pharma
4 followers
Croma is a global player in the minimally invasive aesthetics market and a leading European manufacturer of premium quality hyaluronic acid syringes. The company offers a comprehensive and innovative aesthetics portfolio including botulinum toxin, fillers, lifting threads and biostimulators complemented by its own skincare brand. Founded in 1976 by a pharmacist couple, Croma-Pharma GmbH is a family company headquartered in Austria where it also operates its manufacturing plant. With 550 employees, 13 subsidiaries in Europe and Brazil, two joint ventures and 60 exclusive export partners, it distributes its products in 80 markets globally, including the US, Canada, China, Australia and New Zealand. It also operates as a contract manufacturer in orthopaedics and ophthalmology. For more information please visit cromapharma.com.